Ketamine Clinics in California
74 providers across 53 cities
Browse by City
California is one of the highest-cost ketamine therapy markets in the country, with major hubs in Los Angeles, San Francisco, and San Diego. The state has a robust ecosystem of dedicated ketamine infusion centers, integrative psychiatry practices, Spravato-certified REMS providers, and telehealth platforms serving patients across the state. California's Corporate Practice of Medicine (CPOM) doctrine adds regulatory complexity — the state restricts non-physician ownership of medical practices, shaping how clinics are structured. Patients have access to a wide range of modalities including IV infusion, IM injection, Spravato (available as standalone monotherapy since January 2025), telehealth-delivered sublingual ketamine, integration therapy, and an emerging subcutaneous injection modality. California has state mental health parity laws requiring commercial insurers to cover mental health services on par with physical health, and Medi-Cal covers Spravato with prior authorization for treatment-resistant depression — though not all REMS-certified clinics accept Medi-Cal.
Available Modalities
California providers offer IV ketamine infusion, intramuscular (IM) injection, Spravato (esketamine) at certified REMS centers, at-home and telehealth-delivered sublingual ketamine, integration therapy, and an emerging subcutaneous (SC) ketamine injection modality. Subcutaneous ketamine is administered via a small needle just under the skin and offers bioavailability of approximately 65–93% compared to IV, making it a less invasive and often more cost-accessible alternative. Spravato received FDA approval for standalone monotherapy use in January 2025, meaning it can now be prescribed without a concurrent oral antidepressant. Integration therapy — structured psychotherapy alongside ketamine sessions — is available at a growing number of California providers.
Cost & Pricing
Ketamine therapy in California typically ranges from $450–$650 per session based on verified provider data. While California remains one of the higher-cost ketamine markets, actual per-session pricing is more moderate than widely reported estimates. Los Angeles and San Francisco clinics typically charge $500–$650 per infusion. Package deals for the standard 6-infusion induction series can bring per-session costs lower at some providers. Spravato retail medication costs run $882–$1,663 per dose depending on strength, plus $300–$700+ in mandatory observation fees. With the J&J withMe Savings Program, eligible commercially insured patients may pay as little as $10 per session total. Telehealth-delivered sublingual ketamine is generally less expensive than in-office IV infusion. HSA and FSA payments are accepted at most clinics.
Insurance & Payment
California has state mental health parity laws requiring commercial insurers to cover mental health services at parity with physical health benefits. Medi-Cal (California's Medicaid program) covers Spravato with prior authorization for treatment-resistant depression — though not all REMS-certified clinics accept Medi-Cal, and Janssen's manufacturer copay assistance program cannot be used in conjunction with Medicaid. Off-label IV ketamine is not covered by Medi-Cal. Commercial insurance coverage for IV ketamine is rare, with most patients paying out-of-pocket. HSA and FSA payments are accepted at most clinics.
Conditions Treated
California ketamine clinics treat treatment-resistant depression, anxiety disorders, PTSD, OCD, chronic pain, and suicidal ideation. The state's large mental health provider ecosystem means patients have access to a wide range of complementary therapies alongside ketamine, including integration therapy, somatic work, and mindfulness-based approaches. Several California providers have developed comprehensive ketamine-assisted psychotherapy (KAP) programs combining medication with structured therapeutic support.
What to Expect
Treatment typically begins with an online or in-person medical consultation and psychological screening. For IV infusion, patients receive a 6-session induction series over 2–3 weeks, each session lasting 40–60 minutes in a clinical setting. Telehealth-delivered sublingual ketamine programs typically involve more frequent sessions with remote provider support. Integration therapy, scheduled between or after ketamine sessions, is available at many California providers and is increasingly recommended as part of a comprehensive treatment plan. Patients must arrange transportation after in-office sessions.